Allspring Global Investments
TBIO

Allspring Global Investments’s Telesis Bio, Inc. Common Stock TBIO Stock Holding History

Allspring Global Investments’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-132
Closed -$12K – 2987
2022
Q1 		$12K Buy
132
+12
+10% +$1.82K ﹤0.01% 2965
2021
Q4 		$23K Buy
+120
New +$18.7K ﹤0.01% 2894

Other funds holding TBIO

NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Allspring Global Investments's TBIO Position: Q2 2022 in Review

Allspring Global Investments sold out of Telesis Bio, Inc. Common Stock (TBIO) in Q2 2022, closing a stake of 132 shares — an estimated $12K sold.

Allspring Global Investments first reported a position in TBIO in Q4 2021 and held it in 2 quarters. The position peaked at $23K in Q4 2021. 37 funds tracked by Wall St. Rank hold TBIO as of Q2 2022.

  • Allspring Global Investments reported no remaining Telesis Bio, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Allspring Global Investments sold 132 Telesis Bio, Inc. Common Stock shares in Q2 2022, an estimated $12K.
  • Allspring Global Investments first reported a position in Telesis Bio, Inc. Common Stock in Q4 2021 and held it in 2 quarters.
  • Allspring Global Investments's Telesis Bio, Inc. Common Stock position peaked at $23K in Q4 2021.
  • 37 funds tracked by Wall St. Rank held Telesis Bio, Inc. Common Stock as of Q2 2022.

Based on Allspring Global Investments's 13F filing for Q2 2022, filed 25 Jul 2022.